Literature DB >> 8256581

Ultrastructural observations on neuronal lipofuscin (age pigment) and dense bodies induced by a proteinase inhibitor, leupeptin, in rat hippocampus.

A Nunomura1, T Miyagishi.   

Abstract

The ultrastructure of lipofuscin (age pigment) and dense bodies induced by intraventricular administration of leupeptin, a cysteine proteinase inhibitor, were investigated in the neurons of rat hippocampal dentate gyrus. Four-day treatment with leupeptin (0.5 mg/day) rapidly caused a considerable accumulation of intracytoplasmic dense bodies and swelling of neuronal processes. We demonstrated, as inner structures of the pigments, that penta-laminar structure with a thickness of 12-13 nm and finely granular matrix were exactly common to the leupeptin-induced dense bodies and lipofuscin granules. Furthermore, the transitional stages from lysosomes into the dense granules were observed in the neurons of the leupeptin-treated rats. On the other hand, some morphological differences between the leupeptin-induced dense bodies and lipofuscin granules have been shown: (1) distribution in different cell types, (2) intracytoplasmic location, (3) tendencies to associate with vacuoles, and (4) electron density. The present findings suggested that the decline of the lysosomal protein degradation could play a role in lipofuscinogenesis, especially in the genesis of their electron-dense portion, but some other mechanisms might participate in the formation and accumulation of lipofuscin with aging.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256581     DOI: 10.1007/bf00369443

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Degeneration of neuronal processes in rats induced by a protease inhibitor, leupeptin.

Authors:  S Takauchi; K Miyoshi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Electron microscopical studies on rat brain neurons. Localization of acid phosphatase and mode of formation of lipofuscin bodies.

Authors:  U Brunk; J L Ericsson
Journal:  J Ultrastruct Res       Date:  1972-01

3.  Lipoprotein pigments--their relationship to ageing in the human nervous system. I. The lipofuscin content of nerve cells.

Authors:  D M Mann; P O Yates
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

4.  Properties of neuronal lipofuscin pigment in mice.

Authors:  K Nandy
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

5.  Histochemical studies on the lipo-pigments in the nerve cells. A comparison with lipofuscin and ceroid pigment.

Authors:  N Nishioka; N Takahata; R Iizuka
Journal:  Acta Neuropathol       Date:  1968-09-02       Impact factor: 17.088

6.  [On the neurolipofuscin of the oliva inferior and nucleus dentatus cerebelli in the human brain].

Authors:  H Braak
Journal:  Z Zellforsch Mikrosk Anat       Date:  1971

7.  Inhibition of proteolytic activity of calcium activated neutral protease by leupeptin and antipain.

Authors:  T Toyo-Oka; T Shimizu; T Masaki
Journal:  Biochem Biophys Res Commun       Date:  1978-05-30       Impact factor: 3.575

8.  Mechanisms of lipofuscinogenesis: effect of the inhibition of lysosomal proteinases and lipases under varying concentrations of ambient oxygen in cultured rat neonatal myocardial cells.

Authors:  M R Marzabadi; R S Sohal; U T Brunk
Journal:  APMIS       Date:  1991-05       Impact factor: 3.205

9.  Lipofuscin in the cerebellar cortex of albino rats: an electron microscopic study.

Authors:  H Heinsen
Journal:  Anat Embryol (Berl)       Date:  1979-04-06

10.  Peroxidation of subcellular organelles: formation of lipofuscinlike fluorescent pigments.

Authors:  K S Chio; U Reiss; B Fletcher; A L Tappel
Journal:  Science       Date:  1969-12-19       Impact factor: 47.728

View more
  7 in total

1.  Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus.

Authors:  E Bednarski; C E Ribak; G Lynch
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits.

Authors:  Dun-Sheng Yang; Philip Stavrides; Mitsuo Saito; Asok Kumar; Jose A Rodriguez-Navarro; Monika Pawlik; Chunfeng Huo; Steven U Walkley; Mariko Saito; Ana M Cuervo; Ralph A Nixon
Journal:  Brain       Date:  2014-09-29       Impact factor: 13.501

Review 3.  The role of beta-amyloid in the development of Alzheimer's disease.

Authors:  K Ii
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

4.  Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged.

Authors:  K Ii; H Ito; E Kominami; A Hirano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Cytoskeletal changes in rat cortical neurons induced by long-term intraventricular infusion of leupeptin.

Authors:  S Takauchi; K Miyoshi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 6.  Macroautophagy and aging: The impact of cellular recycling on health and longevity.

Authors:  Jose L Nieto-Torres; Malene Hansen
Journal:  Mol Aspects Med       Date:  2021-09-07

7.  Deficiency of prion protein induces impaired autophagic flux in neurons.

Authors:  Hae-Young Shin; Jeong-Ho Park; Richard I Carp; Eun-Kyoung Choi; Yong-Sun Kim
Journal:  Front Aging Neurosci       Date:  2014-08-25       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.